Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

NCT00834262 · clinicaltrials.gov ↗

COMPLETED

Status

339

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 30
DRUG: biphasic insulin aspart 50
DRUG: biphasic insulin aspart 70

Sponsor

Novo Nordisk A/S